RIO DE JANEIRO, BRAZIL - Brazil’s federally funded Fiocruz Institute said on Saturday, January 23rd, it had begun distributing 2 million ready-to-use AstraZeneca PLC COVID-19 vaccines after they arrived in the country from India on Friday.
Brazil’s government has a deal with AstraZeneca to produce up to 100 million doses of its vaccine locally at Rio de Janeiro’s Fiocruz Institute, but delivery of the active ingredient needed to manufacture them has been plagued by delays from China.
As a result, AstraZeneca agreed to supply the government with 2 million ready-to-use doses made in . . .